Cystic Fibrosis Disease Management and Advanced Drug Delivery Systems

Foreword by Dhruv Galgotia

Preface

1. Introduction to Cystic Fibrosis

Lucy Mohapatra, Deepak Mishra, Alok Shiomurti Tripathi, Alka Kumari, Sambit Kumar Parida, and Bhupendra G. Prajapati

2. Pathophysiological Aspects of Cystic Fibrosis

Sarika Kamble, Akshada Kale, Kishori Ahire, Kalpesh Patil, and Aman Upaganlawar

3. The Role of Microorganisms in Causing Cystic Fibrosis

Neelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, and Bhupendra G. Prajapati

4. Novel Therapeutic Approaches for Cystic Fibrosis

Bhavarth P. Dave, Mehul R. Chorawala, Shivam U. Bhagat, Nidhi N. Shah, Bhupendra G. Prajapati, Priyajeet S. Parekh, and Rakesh B. Patel

5. Cystic Fibrosis: Disease and Advanced Drug Delivery Systems

Ravish J. Patel, Bhupendra G. Prajapati, Nidhi Trivedi, Vidhi Pandya, Amit A. Patel, Samir G. Patel, and Archita Patel

6. Lipid Nanoparticles in Treating Cystic Fibrosis

Devesh U. Kapoor, Bhumi T. Bhatt, Deepak Sharma, Dhiren P. Shah, Bhupendra G. Prajapati, Sudarshan Singh, and Henish Patel

7. Regulations for Monitoring and Management of Cystic Fibrosis

Shivani N. Jani, Hitesh B. Katariya, and Bhupendra G. Prajapati

8. Aerosol Antibiotics in Management of Cystic Fibrosis

Amol D. Gholap, Pankaj R. Khuspe, Deepak K. Bharati, Swapnil Ghorpade, Bhupendra G. Prajapati, and Md. Faiyazuddin

9. Polymeric Nanoparticles in Treating Cystic Fibrosis

Shubhrat Maheshwari, Aditya Singh, Bhupendra G. Prajapati, Vijayshwari Mrityunjay Mishra, and Shivangi Dwivedi

10. Medical Devices Used in Cystic Fibrosis

Abin V. Geevarghese and Bhupendra G. Prajapati

11. Anti-inflammatory Agents Used in Cystic Fibrosis

Swati Pal, Jasveer Kaur, Roshmi Ray, Sushant, Bhupendra G. Prajapati, Akshay Parihar, Himanshu Paliwal, and Venkatanarayana Pappula

12. Challenges for Development of Formulation in Cystic Fibrosis

Sourav Mohanto, Amol D. Gholap, Pankaj R. Khuspe, Navnath T. Hatvate, Sadikali F. Sayyad, Machindra J. Chavan, Mohammed Gulzar Ahmed, Md. Faiyazuddin

13. Epigenetic Modifications in CFTR Regulation, Gene Expression and Its Impact on Cystic Fibrosis Development

Shama Mujawar, Sabyasachi Banerjee, Rutuja Bhoite, and Bhupendra G. Prajapati

14. Heart Failure in Cystic Fibrosis: Treatment and Prognosis

Pratik Thakkar and Akshay Parihar

15. Diagnostic Tools for Cystic Fibrosis

Suchita Waghmare, Rohini Palekar, Lata Potey, Pratiksha Bramhe, Nilesh Rarokar, Pramod Khedekar, Prafulla Sabale, Vidya Sabale, and Bhupendra G. Prajapati

16. Nanomedicine for Cystic Fibrosis

Unnati Patel, Bhupendra G. Prajapati, and Riya Patel

Biography

Bhupendra G. Prajapati, PhD, is a Professor of Pharmacy at Parul University, India, and Adjunct Professor at Silpakorn University, Thailand. With over two decades of experience in academia, research, and industry, he specializes in lipid-based and nano drug delivery systems. A recipient of several prestigious awards, he has published extensively, including many papers and edited books.

Rishabha Malviya, PhD, is an Associate Professor in the School of Medical & Allied Sciences at Galgotias University, India. With research expertise in nanoformulations and targeted drug delivery, he has authored many papers, holds numerous patents, and has edited multiple books. He is a reviewer, editor, and editorial board member of more than 50 national and international journals..

Sonali Sundram, PhD, is an Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, India, focusing on neurodegeneration, nanoformulation, and clinical research. She has edited several books, holds multiple national and international patents, and has spoken at international conferences in Europe.

Akshay Parihar, MPharm, is an Assistant Professor in the Faculty of Pharmaceutical Sciences, Institute of Chartered Financial Analysts of India University, India, and a doctoral researcher at Ganpat University, specializing in novel drug delivery systems for improved therapeutic outcomes in cystic fibrosis.